News

Hospitalists shine in study of heart failure outcomes


 

AT THE HFSA ANNUAL SCIENTIFIC MEETING

References

LAS VEGAS – When it comes to managing patients hospitalized for heart failure, academic hospitalists are the experts – and cardiologists, primary care physicians, and nephrologists are the students.

That’s the lesson Dr. Paul M. Ndunda drew from his retrospective cohort study of 1,735 patients hospitalized for heart failure at three community hospitals. The patients admitted by members of the three teaching hospitalist groups had the lowest inpatient mortality, mean length of stay, and 30-day readmission rates compared to the other admitting physicians.

Although these data aren’t risk adjusted and its certainly possible that the academic hospitalists culled patients with a more favorable risk profile, it’s also likely that the explanation for the outcome differences is multifactorial and that specialty-specific differences in the care delivery process played a role. Indeed, it would appear that the hospitalist model of management of heart failure patients holds lessons of value for other types of physicians, Dr. Ndunda asserted at the annual meeting of the Heart Failure Society of America.

It’s also noteworthy that the teaching hospitalist groups achieved patient outcomes that were by and large better than the nonteaching hospitalist groups, added Dr. Ndunda of the University of Kansas, Wichita.

The major caveat, he conceded, is that outcomes weren’t risk adjusted. This takes on added weight in light of the fact that the teaching hospitalists’ patients were significantly younger than other physicians’ patients were. They were also more likely to be discharged home.

Dr. Ndunda reported having no financial conflicts with regard to this study.

[RW] Academic hospitalists know how to optimize heart failure outcomes

[RW] Academic hospitalists know how to optimize heart failure outcomes

bjancin@frontlinemedcom.com

Recommended Reading

Prednisolone, immunotherapy ineffective for most tuberculous pericarditis
MDedge Internal Medicine
Beta-blockers no help for heart failure with atrial fib
MDedge Internal Medicine
Wearable defibrillator impresses as bridge to ICD decision
MDedge Internal Medicine
Type 2 diabetes boosts risk of death in heart failure patients by 70%
MDedge Internal Medicine
FDA finalizes medical device cybersecurity guidance
MDedge Internal Medicine
What about LCZ696 for heart failure with preserved ejection fraction?
MDedge Internal Medicine
Should LCZ696 receive a level I indication?
MDedge Internal Medicine
CardioMEMS heralds new proactive era in heart failure management
MDedge Internal Medicine
Heart failure readmission cuts may be a phone call away
MDedge Internal Medicine
Heart failure hospitalizations jump after major holidays
MDedge Internal Medicine